Future Market Insights (FMI), a globally recognized market intelligence and consulting firm, has revealed a promising forecast for the Global Varicella vaccine industry. The latest report from FMI anticipates a robust 6.3% Compound Annual Growth Rate (CAGR) for the market from 2022 to 2032, with a projected value of US$ 5.76 Billion by the conclusion of the assessment period.
The surge in global initiatives to combat infectious diseases, specifically chickenpox and measles, has been a key driver in the escalating demand for varicella vaccines. Governments worldwide are intensifying their efforts to mitigate the prevalence of these diseases, propelling the varicella vaccine market towards a luminous and expansive future.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14843
From 2015 to 2021, the market flourished significantly, reaching US$ 2.93 Billion by the end of the said historical period. The Chickenpox segment is likely to offer remunerative opportunities for the Global Varicella Vaccines Industry. Several emerging economies are making significant developments in their healthcare sector, thereby, providing lucrative opportunities to players in the market.
Global Varicella Vaccines Industry Key Takeaways:
- Global Varicella Vaccines Industry to surpass US$ 3 Billion in value by 2022-end
- By application, chickenpox immunization is expected to record a 7.1% CAGR until 2032
- By product, monovalent vaccines contributed 73.2% of the total market value in 2021
- North America is the fastest-growing market, registering a 6.7% value CAGR
- South Asia to be the most opportunistic market, accumulating a market value of US$ 320 Million by 2032
- China to be a key contributor in the East Asian market, growing at a 5.9% CAGR
Understanding the assumptions of the study. Ask from Market Research Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-14843
Global Varicella Vaccines Industry Competitive Landscape
Eminent players in the Global Varicella Vaccines Industry include Bio-Med Pvt. Limited, Pfizer Inc., Emcure Pharmaceuticals Limited, Merck & Co Inc., Sanofi, and Novo Medi Sciences among others. Recent key developments among players include:
- In January 2022 – Pfizer Inc. and BioNTech SE announced a new research, development, and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV) a debilitating, disfiguring, and painful disease that impacts about one in three people in the United States during their lifetime. This is the third collaboration between Pfizer and BioNTech in the infectious diseases field.
- In July 2021 - GC LabCell and GC Cell announced a merger agreement to combine in an all-stock transaction. The transaction brings together two iconic South Korean biopharmaceutical companies, highly complementary portfolios with a robust broad cell therapy R&D pipeline and cutting-edge manufacturing capabilities to accelerate growth and enhance value creation.
More Valuable Insights
In its new offering, Future Market Insights presents an unbiased analysis of the Global Varicella Vaccines Industry, presenting a historical analysis from 2015 to 2021 and forecast statistics for 2022-2032.
The study reveals essential insights based on product (monovalent, combination) by application (chickenpox immunization, herpes zoster immunization, mumps, measles and rubella & varicella (MMRV) immunization) and by end-user (hospitals, clinics, and others), across seven major regions (North America, Europe, South Asia, East Asia, Oceania, Middle East & Africa, and Latin America)
For in-depth insights, Download a PDF Brochure
https://www.futuremarketinsights.com/reports/brochure/rep-gb-14843
Key Segments Covered in the Varicella Vaccines Industry Survey
Global Varicella Vaccines Industry by Product:
- Monovalent Varicella Vaccines
- Combination Varicella Vaccines
Global Varicella Vaccines Industry by Application:
- Varicella Vaccines for Chickenpox Immunization
- Varicella Vaccines for Herpes Zoster Immunization
- Varicella Vaccines for Mumps, measles, rubella & varicella (MMRV) Immunization
Global Varicella Vaccines Industry by End User:
- Varicella Vaccines for Hospitals
- Varicella Vaccines for Clinics
- Varicella Vaccines for Other End Users
Global Varicella Vaccines Industry by Region:
- North America Varicella Vaccines Market
- Europe Varicella Vaccines Market
- South Asia Varicella Vaccines Market
- East Asia Varicella Vaccines Market
- Oceania Varicella Vaccines Market
- Middle East & Africa Varicella Vaccines Market
- Latin America Varicella Vaccines Market
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
